Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Global Sterile Injectable Drugs Market to Reach US$ 900 Bn in Revenues by 2025

Press release Description

Albany, New York, March 23, 2018: A new informative study titled “Sterile Injectable Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025” has recently been added to the repository of Market Research Reports Search Engine (MRRSE). According to the report, the global sterile injectable drugs market is likely to grow at a CAGR of 11.1% during the assessment period, and surpass US$ 900 Bn in revenues by 2025.

According to the report, the demand for sterile injectable drugs is likely to grow on account of growing emphasis on developing effective treatment mechanisms against cardiovascular diseases and cancer. The relatively shorter timeframe for approving sterile injectable drugs is another key factor that has led to an increase in demand.

The report segments the global sterile injectable drugs market into drug class, distribution channel, type, indication and region. Geographically, the market is divided into key regions globally which are North America, Latin America, Europe, Asia Pacific and Middle East & Africa.

By drug class, monoclonal antibodies are likely to remain the leading segment in terms of revenue. The monoclonal antibodies segment is likely to account for nearly 26% in revenue share, whereas insulin and vaccines are the other key segments in the market.

The report also offers detailed analysis and forecast on the basis of distribution channel and disease indication. The key segments as per disease indication include autoimmune, metabolic disorders, cardiology, hematology, infectious diseases, and oncology. On the basis of distribution channel, the key segments include hospital pharmacy, ecommerce, and retail pharmacy.

By region, North America is likely to remain one of the leading markets for sterile injectable drugs. The demand for sterile injectable drugs in North America is likely to remain concentrated in the US. The shorter FDA approval cycles for sterile injectable drugs is a key factor promoting their growth in North America. In addition to North America, Asia Pacific is another key market for sterile injectable drugs globally. The demand for these drugs in Asia Pacific is robust in China and India, and it is expected that the region will offer lucrative opportunities for manufacturers during the assessment period.

The report profiles some of the leading players operating in the market. Some of these players are Baxter International, Pfizer, Inc., Sanofi S.A., GlaxoSmithKline Plc., Merck & Co., Inc., AstraZeneca, Novartis AG, Novo Nordisk A/S, Johnson & Johnson Services, Inc. and Gilead Sciences, Inc.

Browse Full Global Sterile Injectable Drugs Market Report with TOC : https://www.mrrse.com/sterile-injectable-drugs-market-industry

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559
Email: sales@mrrse.com